COVID-19 considerations for SEC reporting companies

The COVID-19 pandemic has raised a number of issues specific to public companies that file reports with the Securities and Exchange Commission.  Among the issues impacted by COVID-19 that we will discuss in this webcast will be:

  • Risk factors and forward-looking information disclosures
  • Other SEC disclosure topics
  • Earnings releases, earnings calls and guidance
  • Considerations for correcting or updating disclosures
  • Regulation FD issues
  • Insider trading and share repurchase issues
  • Shareholder meeting logistics
  • SEC filing deadline relief
  • SEC comment period extensions

Tuesday, April 7, 2020
1 p.m. EDT

 

Latest Articles

Pressure Builds for Better ESG Leadership at Companies

Last week saw a legitimately dramatic vote take place in the U.S. House of Representatives. By just one vote, the House passed sweeping legislation re...

No Easy Answers to Ransomware Riddle

Imagine you’re a director of a real estate company tasked with hiring a new chief executive. “Understands best practices in information security...

PCAOB Overhaul Latest Sign of Gensler’s Ambitious Agenda

Gary Gensler developed a reputation for ruthless efficiency while heading the Commodity Futures Trading Commission from 2009 to 2014. He’s living up...